跳至主要内容
临床试验/NCT03985085
NCT03985085Unknown不适用

PrEP, Sexually Transmitted Infections, Contraception, Hepatitis B Virus, and Sexual Health for Female Sex Workers in Côte d'Ivoire

ANRS, Emerging Infectious Diseases1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2019年11月26日最近更新:
适应症

试验速览

阶段
不适用
入组人数
500
试验地点
1
主要终点
Composition of the vaginal microbiota

研究概览

简要总结

The PRINCESSE study will implement a comprehensive package of services in sexual and reproductive health for female sex workers in the region of San Pedro in Cote d'Ivoire, including screening, prevention and treatment for HIV, viral hepatitis B, sexually transmitted infections and family planning. All services will be available in mobiles clinics operating on prostitution sites and organized for a chronic follow-up of participants.

详细描述

PRINCESSE is a single-arm interventional cohort of 500 female sex workers (FSWs) in San Pedro, Cote d'Ivoire (400 HIV-negative FSW and 100 HIV-positive FSW).

It consists in the implementation of a comprehensive sexual and reproductive health care package for female sex workers in Côte d'Ivoire, combining an HIV PrEP offer (for HIV- FSW) with early treatment of HIV+ FSW, management of HBV infection (testing, vaccination and treatment), testing and treatment of sexually transmitted infections (STIs) and their consequences, a contraception offer, a quarterly screening of pregnancies, menstrual management counselling and identification of addiction.

This healthcare package will be available both in mobile clinics organized for a quarterly follow-up (10 intervention sites, each site being visited every two weeks) and in the fixed clinic of the partner community-based NGO, at the discretion of each female participant.

The main objective is to develop, document and analyze a community-based healthcare package combining testing, prevention tools including pre-exposure prophylaxis (PrEP), immediate HIV treatment, management of Hepatitis B virus and sexual and reproductive health (SRH)

Specific objectives are:

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Being a woman over 18 years of age
  • Self-reporting as being a sex worker
  • Wishing to enrol in a regular clinical follow-up
  • Agreeing to participate in the study and signing the informed consent form
  • Regardless of HIV status (infected or not)
  • Whether or not the participant has already taken antiretrovirals
  • Whether or not the participant is already followed by Aprosam

排除标准

  • Participation in another biomedical and/or behavioural study on HIV, viral hepatitis or Sexually Transmitted Infections

结局指标

主要结局

Composition of the vaginal microbiota

时间窗: up to 12 months

Percentage of cervical lesions at M0 and M12

Occurrence of an unwanted pregnancy in the last 12 months

时间窗: up to 24 months

Proportion with increase in transaminase level (flares) after PrEP discontinuation

时间窗: within 12 months after PrEP discontinuation

Among those who started and stopped PrEP and with a positive HBs antigen

Number of adverse social events occurring in the daily life of participants

时间窗: over 24 months

Assessment of adverse social events occurring in the daily life of participants

Completion rate of quarterly visits

时间窗: up to 24 months

Proportion of completed study visits

Proportion with at least one diagnosed STI

时间窗: up to 24 months

Occurrence of virological failure

时间窗: over 24 months (survival analysis)

Among those HIV-infected and having initiated antiretroviral treatment, proportion with two consecutive detectable viral loads

HBV vaccination rate

时间窗: over 24 months

among those needing hepatitis B vaccination, proportion with complete vaccination (3 doses if HIV-negative, 8 doses if HIV-positive) at the end of the trial

Percentage of HPV infection and distribution of subtypes

时间窗: up to 12 months

Initiation of PrEP

时间窗: over 24 months

Among those eligible for PrEP, proportion having initiating PrEP

Adherence to PrEP

时间窗: up to 24 months

among those on PrEP, proportion being adherent (measured through self-report, pill count and drug detection in plasma)

Number of participants in HIV care at 18 months (retention)

时间窗: 18 months

Among those HIV-infected at baseline

Initiation and number of participants on TDF (retention) for patients with a treatment for HBV mono-infection

时间窗: over 24 months

among those with positive HBs-antigen and a F3-F4 fibrosis

Percentage of resistant bacterial STIs

时间窗: up to 12 months

Percentage of M.genitalium infections with mutations resistant to macrolide and fluoroquinolone at M0 and M12 Percentage of N.gonorrhoeae infections with resistance genes resistant to fluoroquinolone, ceftriaxone and cyclin at M0 and M12

Percentage of acceptability of different forms of long-acting PrEP for different sex workers profiles

时间窗: over 12 months

Percentage of acceptability will be measured with in-depth individual interviews conducted with sex workers using a semi-structured interview guide including a biographical grid

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验